| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 36-week db/db+aav9-RDH10-1 | Genotype:db/db | Treatment:aav9-rdh10 | ng/ml |
| Reversed phase POSITIVE ION MODE | 36-week db/db+aav9-RDH10-2 | Genotype:db/db | Treatment:aav9-rdh11 | ng/ml |
| Reversed phase POSITIVE ION MODE | 36-week db/db+aav9-RDH10-3 | Genotype:db/db | Treatment:aav9-rdh12 | ng/ml |
| Reversed phase POSITIVE ION MODE | 36-week db/db+atRA-1 | Genotype:db/db | Treatment:all-trans retinoic acid | ng/ml |
| Reversed phase POSITIVE ION MODE | 36-week db/db+atRA-2 | Genotype:db/db | Treatment:all-trans retinoic acid | ng/ml |
| Reversed phase POSITIVE ION MODE | 36-week db/db+atRA-3 | Genotype:db/db | Treatment:all-trans retinoic acid | ng/ml |
| Reversed phase POSITIVE ION MODE | 32-week db/db-1 | Genotype:db/db | Treatment:no | ng/ml |
| Reversed phase POSITIVE ION MODE | 32-week db/db-2 | Genotype:db/db | Treatment:no | ng/ml |
| Reversed phase POSITIVE ION MODE | 32-week db/db-3 | Genotype:db/db | Treatment:no | ng/ml |
| Reversed phase POSITIVE ION MODE | 32-week db/db-4 | Genotype:db/db | Treatment:no | ng/ml |
| Reversed phase POSITIVE ION MODE | 32-week db/db-5 | Genotype:db/db | Treatment:no | ng/ml |
| Reversed phase POSITIVE ION MODE | 32-week db/db-6 | Genotype:db/db | Treatment:no | ng/ml |
| Reversed phase POSITIVE ION MODE | 36-week db/db-1 | Genotype:db/db | Treatment:no | ng/ml |
| Reversed phase POSITIVE ION MODE | 36-week db/db-2 | Genotype:db/db | Treatment:no | ng/ml |
| Reversed phase POSITIVE ION MODE | 36-week db/db-3 | Genotype:db/db | Treatment:no | ng/ml |
| Reversed phase POSITIVE ION MODE | 32-week db/db+Rol-1 | Genotype:db/db | Treatment:retinol | ng/ml |
| Reversed phase POSITIVE ION MODE | 32-week db/db+Rol-2 | Genotype:db/db | Treatment:retinol | ng/ml |
| Reversed phase POSITIVE ION MODE | 32-week db/db+Rol-3 | Genotype:db/db | Treatment:retinol | ng/ml |
| Reversed phase POSITIVE ION MODE | 32-week db/m-1 | Genotype:db/m+ | Treatment:no | ng/ml |
| Reversed phase POSITIVE ION MODE | 32-week db/m-2 | Genotype:db/m+ | Treatment:no | ng/ml |
| Reversed phase POSITIVE ION MODE | 32-week db/m-3 | Genotype:db/m+ | Treatment:no | ng/ml |
| Reversed phase POSITIVE ION MODE | 36-week db/m-1 | Genotype:db/m+ | Treatment:no | ng/ml |
| Reversed phase POSITIVE ION MODE | 36-week db/m-2 | Genotype:db/m+ | Treatment:no | ng/ml |
| Reversed phase POSITIVE ION MODE | 36-week db/m-3 | Genotype:db/m+ | Treatment:no | ng/ml |
| Reversed phase POSITIVE ION MODE | RDH10-CKO-1 | Genotype:"RDH10fl/fl, MYH6-iCre" | Treatment:tamoxifen | ng/ml |
| Reversed phase POSITIVE ION MODE | RDH10-CKO-2 | Genotype:"RDH10fl/fl, MYH6-iCre" | Treatment:tamoxifen | ng/ml |
| Reversed phase POSITIVE ION MODE | RDH10-CKO-3 | Genotype:"RDH10fl/fl, MYH6-iCre" | Treatment:tamoxifen | ng/ml |
| Reversed phase POSITIVE ION MODE | RDH10-FL-1 | Genotype:RDH10fl/fl | Treatment:tamoxifen | ng/ml |
| Reversed phase POSITIVE ION MODE | RDH10-FL-2 | Genotype:RDH10fl/fl | Treatment:tamoxifen | ng/ml |
| Reversed phase POSITIVE ION MODE | RDH10-FL-3 | Genotype:RDH10fl/fl | Treatment:tamoxifen | ng/ml |
Return to study ST002474 main page
Download data matrix(Retinol Dehydrogenase 10 Reduction Mediated Retinol Metabolism Disorder Promotes Diabetic Cardiomyopathy in Male Mice. Reversed phase POSITIVE ION MODE)
- Metabolomics Workbench
|